NSI Equity Snapshot
AJANTPHARM Weekly Equity Report
Ajanta Pharma Limited
What the company does
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
What the weekly tape is saying
AJANTPHARM closed the latest completed week at 3,131 INR. The 4-week return is -1.5% and the 12-week return is 7.8%. Trend Signal is active, Market Dynamics is 0.13. Setup signature: Balanced read with a 71/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 2,844 INR
- Vs Trend Line
- 10.1%
- Fair Value
- 2,456 INR
- Vs Fair Value
- 27.5%
- 52W High
- 3,315 INR
- 52W Low
- 2,304 INR
- Drawdown
- -5.5%
- Range Position
- 81.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 24 weeks
- 52W Active Weeks
- 26
- 52W Active Breadth
- 50.0%
- Sector Scope
- IN Healthcare
- Sector Rank
- 30 of 161
- Sector Percentile
- 81.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IN Healthcare
- Tracked Peers
- 100
- 4W Rank
- 67 of 100
- Avg 1W
- 2.2%
- Avg 4W
- 5.7%
- Trend Breadth
- 55.0%
- Positive MD
- 90.0%
IN Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 92
- 4W Rank
- 65 of 92
- Avg 1W
- 2.0%
- Avg 4W
- 7.4%
- Trend Breadth
- 50.0%
- Positive RS
- 65.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.13
- 4W MD Change
- 253.4%
- Relative Strength
- 21.07
- 4W RS Change
- -15.9%
- Expectation
- Undecided
- Probability
- 49.87%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 764.1K
- 13W Average
- 566.5K
- 52W Average
- 575.9K
- Vs 13W
- 1.3x
- Vs 52W
- 1.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.7%
- 52W Volatility
- 3.4%
- Upside Weeks
- 28
- Downside Weeks
- 24
- Downside Breadth
- 46.2%
- Avg Gain / Loss
- 2.9% / -2.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NSI
- Country
- IN
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- INR
- Market Cap
- 365.9B
Opportunity signals
- Trend Signal is active with a 24-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 3,131 INR | 5.2% | 2,844 INR | 2,456 INR | 0.13 | 21.07 | 764.1K | On |
| 5 Jun 2026 | 2,976 INR | 1.6% | 2,823 INR | 2,445 INR | 0.22 | 16.92 | 665.4K | On |
| 29 May 2026 | 2,929 INR | -5.7% | 2,807 INR | 2,435 INR | 0.38 | 14.68 | 514.4K | On |
| 22 May 2026 | 3,108 INR | -2.2% | 2,791 INR | 2,424 INR | 0.29 | 21.31 | 445.1K | On |
| 15 May 2026 | 3,177 INR | 4.7% | 2,767 INR | 2,412 INR | 0.04 | 25.07 | 1.0M | On |
| 8 May 2026 | 3,035 INR | 7.5% | 2,742 INR | 2,400 INR | -0.36 | 17.50 | 1.2M | On |
| 1 May 2026 | 2,823 INR | 2.1% | 2,721 INR | 2,388 INR | -0.69 | 10.51 | 213.9K | On |
| 24 Apr 2026 | 2,765 INR | -0.9% | 2,706 INR | 2,378 INR | -0.67 | 8.96 | 359.5K | On |
| 17 Apr 2026 | 2,790 INR | -0.6% | 2,695 INR | 2,368 INR | -0.50 | 7.99 | 442.8K | On |
| 10 Apr 2026 | 2,806 INR | 0.5% | 2,686 INR | 2,358 INR | -0.14 | 10.03 | 385.4K | On |
| 3 Apr 2026 | 2,791 INR | -0.6% | 2,677 INR | 2,348 INR | 0.41 | 16.01 | 270.8K | On |
| 27 Mar 2026 | 2,808 INR | -3.3% | 2,670 INR | 2,338 INR | 0.82 | 16.49 | 368.4K | On |
| 20 Mar 2026 | 2,905 INR | -4.2% | 2,658 INR | 2,327 INR | 1.22 | 19.24 | 753.0K | On |
| 13 Mar 2026 | 3,031 INR | 1.3% | 2,648 INR | 2,316 INR | 1.33 | 24.46 | 790.8K | On |